StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) bonds

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.39−0.03 (-7.14%)

Close on Nov 16, 2026Market cap $2.02MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$1.73M
Long-term debt
Net debt
-$2.06M
After $3.79M of cash
Implied interest rate
0.35%
FY2025 interest ÷ average debt
Interest coverage
-685.2×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2015

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Jaguar Health's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Accredited Investors6.00%$350.00K–
March 2024 First Insurance Financing9.30%$97.00K$0
March 2025 First Insurance Financing5.00%$60.00K$0
March 2026 First Insurance Financing9.20%$46.00K$32.00K
May 2024 First Insurance Financing9.20%$519.00K$0
May 2025 First Insurance Financing8.30%$510.00K$0
May 2026 First Insurance Financing7.30%$376.00K$339.00K
Streeterville Note8.00%$10.80M–
Tempesta Note2.50%$550.00K–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?